ASX 200: CSL 1H 2023 earnings preview
Australia's third largest ASX 200 company, CSL, is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023 AEDT.
When will CSL report its latest earnings?
CSL is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023 AEDT.
What should traders look out for?
CSL Limited (CSL) is Australia's largest drugmaker, one of the world's largest biotech companies, a leader in flu treatments and plasma protein therapies, and a leading provider of in-licensed vaccines.
CSL is the third largest company in the ASX 200, only behind BHP and CBA. It has an index weighting of ~6.8% and sits under the ASX Heath Care Sector.
Following the acquisition of Vifor Pharma (a Swiss biotech specialising in renal disease and iron deficiency), CSL has a bigger footprint within the industry and a more diversified earnings stream than ever before.
Covid-19 provided a headwind for CSL's supply chains and the collection of plasma, an essential raw material used to produce many of CSL's therapies, which accounts for almost half of CSL's sales.
However, with Covid-19 now mainly in the rear vision mirror, plasma donations in the US are rising, supported by an increase in plasma collection centres and as donors use payments to offset rising living costs. The increase in collections has come despite labour shortages.
Increased collection volumes will help accelerate CSL’s Behring business which develops and manufactures treatments for bleeding disorders, immune deficiencies, and other rare diseases.
CSL earnings – what to expect
CSL’s earnings are heavily screwed to the first half of the year and will be boosted by the Vifor acquisition. There is also the possibility of a $ 200m gain due to movements in the currency.
Full Year NPAT is expected to be in the range of US$2700-$2800m, with approximately US$1650m coming in the first half. The company is expected to pay an interim dividend of US$1.08 per share.
CSL revenues
CSL shares technical analysis
After breaking out of a long-term trend channel in early February, CSL failed to extend the move above the strong layer of resistance at $320, coming from November 2021 and November 2020 highs.
Since then, the share price of CSL has fallen back into the safety of its long-standing trend channel, postponing, for now, a test of the all-time $342.75 high.
This leaves the share price of CSL delicately perched above a layer of horizontal support at $305/300, and if it falls below there, it would warn that the break higher has failed and of another round of sideways price action within the trend channel.
CSL daily chart
Summary
CSL is scheduled to report its 1H2023 earnings on Tuesday, February 14th, 2023. The market will look for revenue and margin growth as volumes return to and exceed pre-pandemic levels, aided by the acquisition of Vifor.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Start trading forex today
Find opportunity on the world’s most-traded – and most-volatile – financial market.
- Trade spreads from just 0.6 points on EUR/USD
- Analyse with clear, fast charts
- Speculate wherever you are with our intuitive mobile apps
See an FX opportunity?
Try a risk-free trade in your demo account, and see whether you’re onto something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See an FX opportunity?
Don’t miss your chance – upgrade to a live account to take advantage.
- Get spreads from just 0.6 points on popular pairs
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See an FX opportunity?
Don’t miss your chance. Log in to take your position.
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
